Evidence map›Paper›PMID 32246359›Full record

ArticleAIDS and behavior2020

HIV Treatment Knowledge in the Context of "Treatment as Prevention" (TasP).

Margaret M Paschen-Wolff, Aimee N C Campbell, Susan Tross, Michael Castro, Hayley Berg, Sarah Braunstein, Christine Borges, Don Des Jarlais

Abstract read
In one paragraph

Article in AIDS and behavior, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Margaret M Paschen-WolffDivision on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center at New York State Psychiatric Institute, 1051 Riverside Drive, Box 120, New York, NY, 10032, USA. margaret.paschen-wolff@nyspi.columbia.edu.
Aimee N C CampbellDivision on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center at New York State Psychiatric Institute, 1051 Riverside Drive, Box 120, New York, NY, 10032, USA.
Susan TrossDivision of Gender, Sexuality, and Health, Department of Psychiatry, HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA.
Michael CastroBureau of Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, Long Island City, NY, USA.
Hayley BergDepartment of Epidemiology and Global Health, New York University School of Global Public Health, New York, NY, USA.
Sarah BraunsteinBureau of HIV Prevention and Control, New York City Department of Health and Mental Hygiene, Long Island City, NY, USA.
Christine BorgesBureau of Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, Long Island City, NY, USA.
Don Des JarlaisDepartment of Epidemiology and Global Health, New York University School of Global Public Health, New York, NY, USA.

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Risk Factors for HIV/AIDS in Drug UsersR01DA003574 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C, MCKNIGHT, COURTNEY · 1986 to 2025
$16.2M
INSPIRE : Interdisciplinary Social and Behavioral Science Prevention and Intervention REsearch in HIVT32MH019139 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Claude Ann Mellins, Jae M. Sevelius · 1989 to 2026
$10.8M
Evaluating ART for All HIV Seropositives: Can it work with the hardest cases?R01DA035707 · NIDA · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI CAMPBELL, AIMEE N, DES JARLAIS, DON C · 2013 to 2017
$3.1M
NIDA NIH HHS R01 DA003574NIDA NIH HHS R01 DA035707NIMH NIH HHS P30 MH043520NIMH NIH HHS P30 MH43520NIMH NIH HHS T32 MH019139
6 · The paper itself

Abstract

According to 2012 universal ART guidelines, as part of "treatment as prevention" (TasP), all people living with HIV (PLWH) should immediately initiate antiretroviral therapy post-diagnosis to facilitate viral suppression. PLWH who are virally suppressed have no risk of sexually transmitting HIV. This study used descriptive analysis of quantitative data (N = 99) and thematic analysis of qualitative interviews (n = 36) to compare participants recruited from a hospital-based detoxification (detox) unit, largely diagnosed with HIV pre-2012 (n = 63) vs. those recruited from public, urban sexual health clinics (SHCs), mainly diagnosed in 2012 or later (n = 36). Detox participants were significantly more knowledgeable than SHC participants about HIV treatment, except regarding TasP. SHC participants' desire for rapid linkage to care and ART initiation was in line with 2012 universal ART guidelines and TasP messaging regarding viral suppression. More targeted messaging to PLWH pre-2012 could ensure that all PLWH benefit from scientific advances in HIV treatment.

Indexed as

Guidelines as TopicHealth Knowledge, Attitudes, PracticeRetention in CareAntiretroviral Therapy, Highly ActiveFemaleHIV InfectionsHumansInterviews as TopicMaleNew York CityQualitative ResearchTreatment Adherence and ComplianceAntiretroviral treatmentHealth knowledgeHIV/AIDSTreatment as prevention

Identifiers

PMID32246359
PMCPMC7483279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.